Your search history is turned on.
Date: April 2, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, MATHIESEN, Jeffrey S, an officer of the reporting issuer noted below have examined this Form 13- 502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised rea...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...
Date: April 2, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
EDGAR PDF Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the Fiscal Year Ended December 31, 2023 or Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the t...
EDGAR PDF Exhibit 31.2 Certification of Chief Financial Officer of Periodic Report Pursuant to Rule 13a-14(a) and Rule 15d-14(a) I, Jeffrey S. Mathiesen, certify that: 1. I have reviewed this annual report on Form 10-K of Helius Medical Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or ...
EDGAR PDF Exhibit 31.1 Certification of Chief Executive Officer of Periodic Report Pursuant to Rule 13a-14(a) and Rule 15d-14(a) I, Dane C. Andreeff, certify that: 1. I have reviewed this annual report on Form 10-K of Helius Medical Technologies, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit...
EDGAR PDF Table of Contents 55 ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes included elsewhere in this Form 10-K. Further, you ...
EDGAR PDF Table of Contents 89 INDEX TO CONSOLIDATED FINANCIAL STATEMENTS REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (BAKER TILLY US, LLP; MINNEAPOLIS, MN; PCAOB ID #23) F-1 CONSOLIDATED BALANCE SHEETS F-3 CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS F-4 CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY F-5 CONSOLIDATED STATEM...
Date: November 9, 2023 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
EDGAR PDF Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transitio...
EDGAR PDF EXHIBIT 31.1 CERTIFICATIONS I, Dane C. Andreeff, certify that: 1) I have reviewed this report on Form 10-Q for the period ended September 30, 2023 of Helius Medical Technologies, Inc. 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements ...
EDGAR PDF EXHIBIT 31.2 CERTIFICATIONS I, Jeffrey S. Mathiesen, certify that: 1) I have reviewed this report on Form 10-Q for the period ended September 30, 2023 of Helius Medical Technologies, Inc. 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the stateme...